First-pass extracted concept

ChRGR

Candidate: toolkit itemType: construct pattern2 source documents0 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

ChRGR is presented in the supplied summary as a strategically designed channelrhodopsin variant relevant to operational comparisons among engineered variants. It fits the review's focus on kinetics and other functional properties.

Source 1DOI PubMed

ChRGR is described in the supplied summary as an excitatory channelrhodopsin variant. Its highlighted properties are rapid on-off kinetics and minimal desensitization.

Source 2DOI PubMed

Resources required

It requires expression in target cells and optical stimulation.

Source 1DOI PubMed

The provided evidence supports standard optogenetic expression and illumination requirements, but does not specify delivery or hardware details.

Source 2DOI PubMed

What problem it solves

It addresses the need for channelrhodopsin variants with improved operational behavior for optogenetic actuation.

Source 1DOI PubMed

It addresses the need for faster and more stable optical excitation behavior than some nearby alternatives.

Source 2DOI PubMed

Alternatives

The supplied summary places it among other engineered variants such as ReaChR, CatCh, Chronos, and Chrimson.

Source 1DOI PubMed

The supplied summary places it alongside ChR2 and ChIEF as related excitatory opsin tools.

Source 2DOI PubMed

Evidence Snippets

Explicitly supported variant/tool name recovered in the supplied web research summary as a directly relevant engineered channelrhodopsin variant discussed in review-era literature.

Evidence 1Source 1DOI PubMedprovenance

Supported by the supplied web research summary as an explicit channelrhodopsin variant discussed in the seed review and described as having rapid on-off kinetics and minimal desensitization.

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1review2016Methods in molecular biologyDOI PubMed

1 evidence snippet 0 linked claims

Source 2review2011Addiction BiologyDOI PubMed

1 evidence snippet 0 linked claims

Linked Claims

No linked claims captured.